Here are what the editors at HealthDay consider to be the most important developments in Nephrology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Kidney Disease Affects Revascularization Outcomes
WEDNESDAY, Feb. 27, 2019 (HealthDay News) — The presence of comorbid chronic kidney disease (CKD) negatively impacts myocardial revascularization outcomes in patients with type 2 diabetes mellitus (T2DM), according to a study published in the Feb. 5 issue of the Journal of the American College of Cardiology.
Sertraline Tops CBT for Reducing Depression in Dialysis Patients
TUESDAY, Feb. 26, 2019 (HealthDay News) — For patients receiving maintenance hemodialysis, an engagement interview on treatment acceptance has no effect on acceptance of depression treatment, and depression scores are modestly better with sertraline treatment versus cognitive behavioral therapy (CBT) after 12 weeks of treatment, according to a study published online Feb. 26 in the Annals of Internal Medicine.
2014 to 2017 Saw Improvement in Burnout for U.S. Physicians
MONDAY, Feb. 25, 2019 (HealthDay News) — From 2014 to 2017, there was an improvement in burnout and satisfaction with work-life integration among U.S. physicians, according to a study published online Feb. 22 in the Mayo Clinic Proceedings.
National Health Spending Set to Increase 5.5 Percent Annually
FRIDAY, Feb. 22, 2019 (HealthDay News) — National health spending is projected to increase at an annual rate of 5.5. percent from 2018 to 2027, with fundamental economic and demographic factors the main drivers, according to a report published online Feb. 20 in Health Affairs.
Most Patients Do Not Disclose Complementary Medicine Use
FRIDAY, Feb. 22, 2019 (HealthDay News) — Just one-third of users of biologically based complementary medicine (CM) disclose their use to traditional health care providers, according to a review published online Feb. 7 in Scientific Reports.
Higher Salt Intake in DASH Diet Tied to More Lightheadedness
FRIDAY, Feb. 22, 2019 (HealthDay News) — Higher sodium intake in the context of the Dietary Approaches to Stop Hypertension (DASH) diet is tied to more frequent and severe lightheadedness, according to a study published recently in the Journal of Clinical Hypertension.
Hospital Program Does Not Cut Mortality for Acute Kidney Injury